Literature DB >> 22942548

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging.

Saher S Sabri1, Wael E A Saad.   

Abstract

Balloon-occluded retrograde transvenous obliteration (BRTO) is an endovascular technique used as a therapeutic adjunct or alternative to transjugular intrahepatic shunts (TIPS) in the management of gastric varices. Occlusion balloons are strategically placed to modulate flow within the gastrorenal or gastrocaval shunt to allow stagnation of the sclerosant material within the gastric varix. The approach and complexity of the procedure depends on the anatomic classification of inflow and outflow veins of the varix. Ethanolamine oleate has been described as the main sclerosant used in this procedure. Recently, foam sclerosants have gained popularity as alternative embolization agents, which provide the advantage of better variceal wall contact and potentially less dose of sclerosant.

Entities:  

Keywords:  BRTO; Gastric varices; embolization; liver cirrhosis; portal hypertension; portosystemic shunt

Year:  2011        PMID: 22942548      PMCID: PMC3312158          DOI: 10.1055/s-0031-1284457

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  27 in total

1.  The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices.

Authors:  Sae Jin Park; Jin Wook Chung; Hyo-Cheol Kim; Hwan Jun Jae; Jae Hyung Park
Journal:  J Vasc Interv Radiol       Date:  2010-02-20       Impact factor: 3.464

Review 2.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

3.  Stroke after varicose vein foam injection sclerotherapy.

Authors:  Martin V Forlee; Maria Grouden; Dermot J Moore; Gregor Shanik
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

4.  Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam.

Authors:  Roberto Gandini; Marcello Chiocchi; Daniel Konda; Enrico Pampana; Sebastiano Fabiano; Giovanni Simonetti
Journal:  Cardiovasc Intervent Radiol       Date:  2008-01-03       Impact factor: 2.740

Review 5.  Sclerotherapy and foam sclerotherapy for varicose veins.

Authors:  P Coleridge Smith
Journal:  Phlebology       Date:  2009-12       Impact factor: 1.740

6.  Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.

Authors:  Saher S Sabri; Warren Swee; Ulku C Turba; Wael E A Saad; Auh W Park; Abdullah M Al-Osaimi; Stephen H Caldwell; Alan H Matsumoto; John F Angle
Journal:  J Vasc Interv Radiol       Date:  2011-03       Impact factor: 3.464

7.  Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts.

Authors:  Zhen W Zhuang; Gao J Teng; Robert F Jeffery; John M Gemery; B Janne d'Othee; Michael A Bettmann
Journal:  AJR Am J Roentgenol       Date:  2002-12       Impact factor: 3.959

8.  Risk factors for hemorrhage from gastric fundal varices.

Authors:  T Kim; H Shijo; H Kokawa; H Tokumitsu; K Kubara; K Ota; N Akiyoshi; T Iida; M Yokoyama; M Okumura
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

9.  How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.

Authors:  M Rössle; V Siegerstetter; M Olschewski; A Ochs; E Berger; K Haag
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

10.  Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.

Authors:  Takashi Yamaki; Motohiro Nozaki; Hiyoyuki Sakurai; Masaki Takeuchi; Kazutaka Soejima; Taro Kono
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

View more
  6 in total

Review 1.  Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Authors:  Paul V Suhocki; Matthew P Lungren; Baljendra Kapoor; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 2.  Evolution of Retrograde Transvenous Obliteration Techniques.

Authors:  Mihir Patel; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

Review 3.  Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches.

Authors:  Andrew J Lipnik; Mithil B Pandhi; Ramzy C Khabbaz; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

4.  Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

5.  Variceal bleeding in the small intestine successfully treated with balloon-occluded retrograde transvenous obliteration using N-butyl-2-cyanoacrylate: A case report.

Authors:  Koichi Masuda; Shinsuke Takenaga; Hirokazu Ashida; Hiroya Ojiri
Journal:  Radiol Case Rep       Date:  2018-02-06

6.  The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage.

Authors:  Jiacheng Liu; Chongtu Yang; Songjiang Huang; Chen Zhou; Qin Shi; Kun Qian; Songlin Song; Bin Xiong
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-05       Impact factor: 2.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.